Abstracts

icon abstract

Abstract submission

Deadline for abstract submission for Oral Presentation is 16 January 2019
Deadline for abstract submission for Posters is 20 February 2019

Rules:

  • The Scientific Committee will consider the abstracts not accepted as Oral Presentations for inclusion in the Poster Session.
  • Each person is allowed to submit a maximum of two abstracts as a presenting author: one oral presentation and one poster, or two posters. There is no limit to the number of abstracts submitted as a co-author.
  • Presenting authors of accepted abstracts for Oral Presentation will be notified whether their abstract is accepted by January 2019.
  • The authors of accepted abstracts will be notified by 26 February 2019.
    Abstract presenters are required to finalize their registration before 6 March 2019. Failure to do so, will result in exclusion from the program.
  • Abstracts submitted via email or fax will not be accepted.

How should I write my abstract?

  • The abstract must be divided into the following sections:
    ContextObjectiveMethods Patient(s) Intervention(s) Main Outcome Measure(s) Result(s) Conclusions.
    The abstract cannot be longer than 2500 characters including spaces, and must be plain text: it is not possible to include tables and images, but you may insert data in the text of the abstract.
  • Each person is allowed to submit a maximum of two abstracts on thecongress’ topics as presenting author: one oral presentation and one poster or, alternatively, two posters. There is no limit to the number of abstracts submitted as co-author


Topics

  1. Abortion
  2. Aging and infertility
  3. Androgen Deficiency Syndrome
  4. Androgens
  5. Apoptosis and Oncogenesis
  6. Adolescence
  7. Breast
  8. Cancer and reproduction
  9. Contraception
  10. Corpus Luteum
  11. Cronic Plevic Pain
  12. Cryopreservation
  13. Depression and reproduction
  14. Diabetes, reproduction and pregnancy
  15. DUB (dysfunctional uterine bleeding)
  16. Early pregnancy
  17. Embryo implantation
  18. Emergency Contraception
  19. Endocrine and paracrine control of ovulation
  20. Endometriosis
  21. Estrogens
  22. Ethics and reproduction
  23. Fat tissue distribution and body weight control
  24. Female sexual disfunction
  25. Feto-placental Unit
  1. Genes involved in ovarian development and aging
  2. Genital infections
  3. GDM
  4. GnRH Agonists and Antagonists
  5. Hormone replacement therapy
  6. HPV and Cancer
  7. Hypoactive sexual desire disorders
  8. Hypothalamic Dysfunction
  9. Hysteroscopy
  10. Imaging technology in reproduction
  11. Immune system and reproduction
  12. In vitro maturation
  13. Insulin resistance and gonadal function
  14. Labour and Delivery
  15. Laparoscopic Surgery
  16. Male hypogonadism
  17. Male infertility
  18. Male sexual disfunction
  19. Menopause
  20. Menorrhagia
  21. Metabolic syndrome
  22. Microbiome and Microbiota
  23. OMICS and PMA
  24. Ovarian hyperstimulation
  25. Ovulation induction
  1. Pelvic Floor Dysfunction
  2. Pelvic Inflammatory Disease
  3. Perimenopausal Transition
  4. Placenta
  5. Polycystic ovary
  6. Pre-eclampsia
  7. Pre-implantation diagnosis
  8. Pre-natal diagnosis
  9. Premature delivery
  10. Premature ovarian insufficency
  11. Premenstrual Syndrome, PMDD
  12. Progesterone and progestins
  13. Prolactin and fertility
  14. Puberal development
  15. Recurrent Pregnancy Loss
  16. Reproduction and Mental Health
  17. Sexology and Sexuality
  18. Sexually transmitted diseases
  19. Spermatogenesis
  20. Stem cells
  21. Steroid Receptors
  22. Testis
  23. Uterine Myoma
  24. Vagina
  25. Vulva

Submit the abstract

 

SEND AN ABSTRACT NOW

Create an account for free,
and once in your personal page click on the abstract submission button

Submit the abstract